AtoS SE : Close to a key resistance level
BUY
Conditionne
Stop-loss triggered
Entry price | Target | Stop-loss | Potential |
---|
€132 |
€145 |
€127.5 |
+9.85% |
---|
AtoS SE shares are trading close to a resistance zone which currently limits any upside potential. We expect that this level will be broken due to the stock's technical chart pattern.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths● The company is in a robust financial situation considering its net cash and margin position.
● As regards fundamentals, the enterprise value to sales ratio is at 1 for the current period. Therefore, the company is undervalued.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● The stock is in a well-established, long-term rising trend above the technical support level at 109 EUR
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at EUR 130.75.
● The stock is close to a major daily resistance at EUR 131.7, which should be gotten rid of so as to gain new appreciation potential.
● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.